Critical review of EU BE guideline (Rev.1) [Regulatives / Guidelines]

posted by banusunman – 2008-08-26 18:56 (6517 d 04:28 ago) – Posting: # 2256
Views: 28,468

Dear all,

Here is another one:

On page 5, line 150-151 — the criterion for "adequate wash-out period" is not defined. However, in the previous 2001 NfG, for steady-state designs, it was given as "at least 3-times the terminal half-life". In FDA's 2003 GfI, an adequate washout period was described as "e.g., more than 5 half lives of the moieties to be measured".

Do you think they forgot to define it.. or?

Regards,

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
340 visitors (0 registered, 340 guests [including 17 identified bots]).
Forum time: 23:24 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5